Persistent fasting lipogenesis links impaired ketogenesis with citrate synthesis in humans with nonalcoholic fatty liver
Open accessThe DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Abstract
BACKGROUNDHepatic de novo lipogenesis (DNL) and β-oxidation are tightly coordinated, and their dysregulation is thought to contribute to the pathogenesis of nonalcoholic fatty liver (NAFL). Fasting normally relaxes DNL-mediated inhibition of hepatic β-oxidation, dramatically increasing ketogenesis and decreasing reliance on the TCA cycle. Thus, we tested whether aberrant oxidative metabolism in fasting NAFL subjects is related to the inability to halt fasting DNL.METHODSForty consecutive nondiabetic individuals with and without a history of NAFL were recruited for this observational study. After phenotyping, subjects fasted for 24 hours, and hepatic metabolism was interrogated using a combination of 2H2O and 13C tracers, magnetic resonance spectroscopy, and high-resolution mass spectrometry.RESULTSWithin a subset of subjects, DNL was detectable after a 24-hour fast and was more prominent in those with NAFL, though it was poorly correlated with steatosis. However, fasting DNL negatively correlated with hepatic β-oxidation and ketogenesis and positively correlated with citrate synthesis. Subjects with NAFL but undetectable fasting DNL (25th percentile) were comparatively normal. However, those with the highest fasting DNL (75th percentile) were intransigent to the effects of fasting on the concentration of insulin, non-esterified fatty acid, and ketones. Additionally, they sustained glycogenolysis and were spared the loss of oxaloacetate to gluconeogenesis in favor of citrate synthesis, which correlated with DNL and diminished ketogenesis.CONCLUSIONMetabolic flux analysis in fasted subjects indicates that shared metabolic mechanisms link the dysregulations of hepatic DNL, ketogenesis, and the TCA cycle in NAFL.TRIAL REGISTRATIONData were obtained during the enrollment/non-intervention phase of Effect of Vitamin E on Non-Alcoholic Fatty Liver Disease, ClinicalTrials.gov NCT02690792.FUNDINGThis work was supported by the University of Texas Southwestern NORC Quantitative Metabolism Core (NIH P30DK127984), the NIH/National Institute of Diabetes and Digestive and Kidney Diseases (R01DK078184, R01DK128168, R01DK087977, R01DK132254, and K01DK133630), the NIH/National Institute on Alcohol Abuse and Alcoholism (K01AA030327), and the Robert A. Welch Foundation (I-1804).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Fasting DNL in NAFL subjects is associated with lower ketogenesis and β-oxidation, but increased TCA cycle flux, which preserves estimated hepatic oxygen consumption. (A) Correlation between fasting DNL and ketogenesis measured by in vivo ketone turnover (n = 38), with comparison between subjects without NAFL (non-NAFL) and no DNL [DNL(–)] and NAFL subjects with the highest DNL (Q3). (B) Correlation between fasting DNL and TCA cycle flux measured by in vivo 13C and 2H isotopomer analysis of plasma glucose (n = 38), with comparison between DNL(–) and Q3 subjects. (C) Correlation between fasting DNL and the fraction of acetyl-CoA partitioned to the TCA cycle (vs. ketogenesis) (n = 36), with comparison between DNL(–) and Q3 subjects. (D) Inverse correlation between fasting DNL and the apparent rate of hepatic β-oxidation, determined as [TCA cycle flux] + [2 × ketogenesis] (n = 36), with a comparison between DNL(–) and Q3 subjects. (E) Oxygen consumption, calculated by flux balance analysis of net NADH/FADH2 production, did not correlate with fasting DNL (n = 36) and did not differ between DNL(–) and Q3 subjects. (F) Schema showing acetyl-CoA partitioning between ketogenesis and the TCA cycle during fasting DNL. The shift to TCA cycle metabolism preserves reducing equivalent flux and oxygen consumption when β-oxidation and ketogenesis are suppressed. e–, electron. Pearson correlations were used to test for statistically significant relationships. Statistical significance between groups was determined using a 1-way ANOVA (see Supplemental Figure 2 for all groups). Non-correlative data are presented as mean ± SEM.](https://figures.cochat.ai/paper-figures/af65fb9868fa43469700539397eca2d2/persistent-fasting-lipogenesis-links-impaired-ketogenesis-with-citrate-synthesis-figure-2.jpg)
![Figure 3 Subjects with persistent fasting DNL are intransigent to multiple effects of fasting. Fold changes were determined from plasma/serum measurements after an overnight and a 24-hour fast. (A) Expected physiological changes in normal humans transitioning from the fed to the fasting state. (B) Correlation between fasting DNL and the fold decrease in plasma insulin during a 24-hour fast (n = 34), with comparison between subjects without NAFL (Non-NAFL) and DNL [DNL(–)] and NAFL subjects with the highest DNL (Q3). (C) Correlation between fasting DNL and the fold increase in plasma ketones during a 24-hour fast (n = 34), with comparison between DNL(–) and Q3 subjects. (D) Correlation between fasting DNL and the fold increase in plasma non-esterified fatty acids (NEFAs) during a 24-hour fast (n = 36), with comparison between DNL(–) and Q3 subjects. (E) Persistent fasting DNL among NAFL subjects blunts the normal responses of insulin, ketones, and NEFA to fasting. Pearson correlations were used to test for statistically significant relationships. Statistical significance between groups was determined using a 1-way ANOVA (see Supplemental Figure 3 for all groups). Non-correlative data are presented as mean ± SEM.](https://figures.cochat.ai/paper-figures/59ad585a5d71447cb96d78ed2f1ac539/persistent-fasting-lipogenesis-links-impaired-ketogenesis-with-citrate-synthesis-figure-3.jpg)

![Figure 5 Hepatic oxaloacetate is preferentially utilized for citrate synthesis in subjects with persistent fasting DNL. (A) The competition for oxaloacetate (OAA) by gluconeogenesis (GNG) and citrate synthase impacts the fate of acetyl-CoA. Abundant oxaloacetate facilitates citrate synthase, which outcompetes ketogenesis for acetyl-CoA. The resulting citrate is either oxidized back to oxaloacetate in the TCA cycle or transported from the mitochondria for DNL. (B and C) The absolute rate of gluconeogenesis from oxaloacetate (n = 38) (B) and glycogenolysis (n = 38) (C) was measured by glucose turnover and 2H incorporation into positions C2, C5, and C6 of plasma glucose. (D) A [U-13C3]propionate tracer was used to track oxaloacetate’s relative fate between gluconeogenesis and citrate synthesis. Anaplerosis was traced as [1,2,3-13C] or [2,3,4-13C] oxaloacetate isotopomers, which were diluted to [1,2-13C] or [3,4-13C] isotopomers upon reaction with unlabeled acetyl-CoA in the citrate synthase reaction and a subsequent turn of the TCA cycle (13). These atoms were transmitted to plasma glucose by gluconeogenesis, and isotopomers were detected by 13C-NMR and analysis of the C2 multiplets. (E) Negative correlation between fasting DNL and isotopomers arising from anaplerosis and gluconeogenesis (n = 38). (F) Positive correlation between fasting DNL and isotopomers arising from citrate synthase (n = 38). (G) Negative correlation between fasting DNL and the utilization of oxaloacetate for gluconeogenesis relative to its use by citrate synthase (n = 38). (H) Positive correlation between acetyl-CoA used for ketogenesis and the utilization of oxaloacetate for gluconeogenesis relative to its use by citrate synthase (n = 38). Pearson correlations were used to test for statistically significant relationships. Statistical significance between groups was determined using a 1-way ANOVA. Non-correlative data are presented as mean ± SEM.](https://figures.cochat.ai/paper-figures/ac6e63a0308f492e9d55e67de7aaeb00/persistent-fasting-lipogenesis-links-impaired-ketogenesis-with-citrate-synthesis-figure-5.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Postprandial DNL contributes to 15-26% of liver TAGs in individuals with MASLD49,56 vs. 1-6% in the fasting state in healthy individuals.48”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [48]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Fasting DNL correlated with plasma TAG concentrations48 and was higher in individuals with MASLD.49”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [48]
In the citing paper
“Fu et al.48 found that DNL was still active after 24 h of fasting in individuals (with or without MASLD) with increased lipolysis but reduced ketone production, indicating a sort of metabolic inflexibility.”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Self-citationDonnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Molecular mediators of hepatic steatosis and liver injury
Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772
Self-citationMulti-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics
Puchalska, P., & Crawford, P. A. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.022 · Cited by 1,610
Regulation of hepatic fatty acid oxidation and ketone body production
McGarry, J. D., & Foster, D. W. (1980) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.49.070180.002143 · Cited by 1,460 · cited 5×
“…of ketogenesis provides the periphery with an alternative substrate to dwindling glucose availability, consumes acetyl-CoA, recovers free CoA necessary for accelerated fatty acid processing, and can support an order of magnitude higher rate of β -oxidation than the TCA cycle alone (24, 25).”
InfluentialmTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway
Peterson, T. R., Sengupta, S. S., Harris, T. E., Carmack, A. E., Kang, S. A., Balderas, E., Guertin, D. A., Madden, K. L., Carpenter, A. E., Finck, B. N., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.034 · Cited by 1,229
Lambert, J. E., Ramos–Roman, M. A., Browning, J. D., & Parks, E. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.049 · Cited by 1,069 · cited 1×
“A parallel study of the same subjects revealed a 4-fold higher rate of DNL (6), suggesting that elevated DNL is closely associated with the activation of TCA cycle metabolism in NAFL subjects, regardless of ketogenic state.”
Self-citationKoliaki, C., Szendroedi, J., Kaul, K., Jelenik, T., Nowotny, P., Jankowiak, F., Herder, C., Carstensen, M., Krausch, M., Knoefel, W. T., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.004 · Cited by 1,032 · cited 3×
“However, tracer studies indicate that NEFA oxidation in the hepatic tricarboxylic acid (TCA) cycle is normal in lean NAFL subjects (19) and increased in obese subjects with NAFL (10, 20–23), findings that parallel studies of ex vivo mitochondrial respiration (12, 14).”
Selective versus Total Insulin Resistance: A Pathogenic Paradox
Brown, M. S., & Goldstein, J. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.12.009 · Cited by 965
Cited by
Lipid metabolism in MASLD and MASH: From mechanism to the clinic
Carli, F., Della Pepa, G., Sabatini, S., Vidal Puig, A., & Gastaldelli, A. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101185 · Cited by 147
“Fasting DNL correlated with plasma TAG concentrations 48 and was higher in individuals with MASLD.”
Decoding the Liver-Heart Axis in Cardiometabolic Diseases
Capone, F., Vacca, A., Bidault, G., Sarver, D. C., Kamińska, D., Strocchi, S., Vidal‐Puig, A., Greco, C. M., Lusis, A. J., & Schiattarella, G. G. (2025) · Circulation Research · doi:10.1161/circresaha.125.325492 · Cited by 81
Liver-specific actions of GH and IGF1 that protect against MASLD
Kineman, R. D., del Río-Moreno, M., & Waxman, D. J. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01037-0 · Cited by 54
Hepatic adaptation to chronic metabolic stress primes tumorigenesis
Tzouanas, C. N., Shay, J. E. S., Sherman, M. S., Rubin, A. J., Mead, B. E., Dao, T. T., Tao, J., Lehrich, B. M., Eng, G. M., Patterson-Fortin, J., et al. (2025) · Cell · doi:10.1016/j.cell.2025.11.031 · Cited by 38
Liver insulinization as a driver of triglyceride dysmetabolism
Cook, J. R., Hawkins, M. A., & Pajvani, U. B. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00843-6 · Cited by 35
Metadata
- Authors
- Fu, X., Fletcher, J. A., Deja, S., Inigo-Vollmer, M., Burgess, S. C., & Browning, J. D.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Browning, Jeffrey D.
- Venue
- Journal of Clinical Investigation
- Published
- 2023-05-01
- Volume
- 133
- Issue
- 9
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC10145942
- OpenAlex
- W4327626431
- Cited by
- 30
- References
- 53
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 8 · 2023: 3
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (P30DK127984,R01DK078184,R01DK128168,K01DK133630,K01AA030327)
- Robert A Welch Foundation (I-1804)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- non-alcoholic fatty liver disease, de novo lipogenesis, ketogenesis, hepatic beta-oxidation, citrate synthesis, TCA cycle, fasting, hepatic metabolism, metabolic flux, oxaloacetate, gluconeogenesis, glycogenolysis, insulin resistance, free fatty acids, ketones, steatosis, vitamin E
- MeSH terms
- Citrates, Fasting, Humans, Ketone Bodies, Liver, Citric Acid, Lipogenesis, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Persistent fasting lipogenesis links impaired ketogenesis with citrate synthesis in humans with nonalcoholic fatty liver. https://app.cochat.ai/papers/10.1172/jci167442
- The paper
- Fu, X., Fletcher, J. A., Deja, S., Inigo-Vollmer, M., Burgess, S. C., & Browning, J. D. (2023). Persistent fasting lipogenesis links impaired ketogenesis with citrate synthesis in humans with nonalcoholic fatty liver. Journal of Clinical Investigation. https://doi.org/10.1172/jci167442
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.